How does AI help in ovarian and cervical cancer?
In cervical cancer, AI is helping laboratories read Pap test slides and helping health workers judge photos of the cervix. In ovarian cancer, AI is being tested to tell harmless ovarian cysts from cancer on ultrasound. These uses matter in India, which had about 127,500 new cervical cancer cases in 2022 and where very few women have ever been screened. AI supports trained staff; it does not replace screening, specialist review or a biopsy. Knowing how these tools work helps you ask the right questions.
What the studies show
- Pap tests: in 2024 the US FDA authorised Hologic's Genius digital cytology system, which uses AI to help review cervical cell slides.
- Cervical photos: an NCI-led algorithm spotted precancer on cervical images with an AUC of 0.91, compared with 0.69 for visual inspection; it is still research.
- Ovarian ultrasound: a 2025 Nature Medicine study across 20 centres found AI was 86.3% accurate at judging ovarian masses, compared with 82.6% for experts.
The limits
The ovarian study looked back at past scans, and a trial is planned. WHO still recommends HPV testing from age 30 as the main screening test. AI tools also need testing in Indian clinics before wide use. In India, the bigger gap is that few women are screened at all: an NFHS-5 analysis found only about 1.9% of women aged 30 to 49 had ever been screened. Any test you are offered now is worth taking.
Questions to ask your doctor
Take these to your next appointment:
- Which cervical screening test do you recommend for me, and how often?
- How was my Pap test or scan read, and who checked it?
- Does this ovarian cyst need more tests or a specialist review?
- Should I get the HPV vaccine for my daughter?
Where OncoVOIS fits
OncoVOIS, a CancerFax cancer-navigation app, explains Pap, HPV, ultrasound and biopsy reports in plain words and helps you prepare questions for your gynaecologist or oncologist. It is available on Google Play for Android phones, and the CancerFax team can help with expert opinions and trials.
Sources
1. World Health Organization. New recommendations for screening and treatment to prevent cervical cancer, 2021. https://www.who.int/news/item/06-07-2021-new-recommendations-for-screening-and-treatment-to-prevent-cervical-cancer 2. National Cancer Institute. AI approach outperformed human experts in identifying cervical precancer, 2019. https://www.cancer.gov/news-events/press-releases/2019/deep-learning-cervical-cancer-screening 3. Hologic. FDA clearance of Genius Digital Diagnostics System, 2024. https://www.businesswire.com/news/home/20240131786693/en/ 4. Christiansen F, et al. International multicenter validation of AI-driven ultrasound detection of ovarian cancer. Nature Medicine, 2025. https://doi.org/10.1038/s41591-024-03329-4 5. International Agency for Research on Cancer. Global Cancer Observatory, GLOBOCAN 2022. https://gco.iarc.who.int 6. Cervical cancer screening in India: NFHS-5 analysis. https://pmc.ncbi.nlm.nih.gov/articles/PMC10041275/